A method of diagnosing attention deficient-hyperactivity disorder (ADHD) in a human patient by assessing the level of dopamine transporter in at least one region of the patient's central nervous system, where an elevated level of dopamine transporter in the patient is indicative of ADHD. In embodiments of the invention, assessment of dopamine transporter levels includes assessing binding of a dopamine transporter ligand to the dopamine transporters using PET or SPECT.
CROSS-REFERENCE TO RELATED APPLICATIONS
The present application is a continuation of U.S. application Ser. No. 09/932,302, filed Aug. 17, 2001, now U.S. Pat. No. 7,081,238; said U.S. application Ser. No. 09/932,302 is a continuation-in-part of U.S. application Ser. No. 09/605,621, filed on Jun. 28, 2000, now abandoned, which claims the benefit of provisional application No. 60/141,540, filed on Jun. 28, 1999. All of these applications are incorporated herein by reference.
